ORGN vs SKIN
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Jul 17, 2026
ORGN
SKIN
Investment Advisor Scores
SKIN
AI Analyst Insights
Detailed Metrics Comparison
| Metric | ORGN | SKIN | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 0 | 106.383 | Tie |
| PEG Ratio | 0 | 0.9262 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -91.2% | -6.7% | SKIN |
| Earnings Growth | 266.7% | 0.0% | ORGN |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.6/100 | 60.4/100 | SKIN |
| Profit Margin | 0.0% | -2.0% | ORGN |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | BUY | SKIN |
Relative Price Performance (Last 90 Days)
Current Technical Phase
ORGN
MarkdownPrice below a falling SMA50 (slope -27.3%), weak momentum, RSI 34
SKIN
NeutralMixed signals - no dominant trend phase, RSI 48
Fundamentals Snapshot
| Metric | ORGN | SKIN |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -3.1 | 4.7 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | -0.9% | -0.1% |
| Gross Margin | 0.0% | 0.6% |
| Operating Margin | -34.6% | 0.0% |
| EPS | -48.43 | -0.13 |
| Dividend Yield | — | — |